October 20, 2023
2 min watch
Save
VIDEO: Faricimab shows promising reduction of macular leakage
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this Healio Video Perspective, David A. Eichenbaum, MD, discusses data presented at the Retina Society meeting that looked at angiography and macular leakage in patients with diabetic macular edema.
The data were gathered from the YOSEMITE and RHINE studies and found a reduction in the area of angiographic leakage at 16 weeks in patients treated with faricimab compared with aflibercept, he said.
Published by:
Sources/Disclosures
Collapse
Source:
Eichenbaum D. Faricimab reduces macular leakage vs aflibercept in patients with DME. Presented at: Retina Society meeting; Oct. 11-14, 2023; New York.
Disclosures:
Eichenbaum reports being a speaker, consultant and investigator for Bayer, Genentech and Regeneron.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.